The examples in the table are selected based on that the genes have a mutant frequency greater than 40 in the COSMIC database to show the estimation for the common cases. Due to the limited space, the
We conducted a phase I dose escalation study (NCT03024489) using a classical 3+3 design to determine safety, tolerability, and maximum tolerated dose (MTD) of palbociclib, cetuximab, and IMRT combinat
Publicly available gene expression dataset from TCGA PanCanAtlas.These data are used by Way et al. 2018 Cell Reports and were previously accessed on Synapse (Data Freeze 1.3.1)For more details see htt
